title: A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
abstract: Renal transplant recipients are susceptible to Kaposi's sarcoma (KS) because of treatment with immunosuppressive drugs. Sirolimus, a new immunosuppressive agent, has been successfully used for immune-suppression in kidney transplant recipients. Several studies have shown the potential role of sirolimus to inhibit progression of KS in kidney-transplant recipients. This report details a kidney-transplant recipient with cutaneous KS who had a complete remission in response to sirolimus therapy.
authors: Department of Nephrology, Hacettepe University School of Medicine, Ankara, Turkey.
authors: Rahmi
authors: R
authors: Yilmaz
authors: Hadim
authors: H
authors: Akoglu
authors: Alper
authors: A
authors: Kirkpantur
authors: Saadettin
authors: S
authors: Kilickap
authors: Mustafa
authors: M
authors: Arici
authors: Bulent
authors: B
authors: Altun
authors: Tuncay
authors: T
authors: Aki
authors: Yunus
authors: Y
authors: Erdem
authors: Unal
authors: U
authors: Yasavul
authors: Cetin
authors: C
authors: Turgan
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology; D020123:Sirolimus / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000209:etiology
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus